Co-diagnostics vs Qtrex Quantum
Co-diagnostics is the larger business, with $622,489 of revenue in fiscal 2025 against $289,000 for Qtrex Quantum (2.2 times as much). Qtrex Quantum kept more of each dollar of sales as profit: a net margin of -4574.4% against -7533.6%. Co-diagnostics carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | Co-diagnosticsCODX, 2025 | Qtrex QuantumQTEX, 2025 |
|---|---|---|
| Revenue | $622,489 | $289,000 |
| Revenue growth | -84.1% | — |
| Net income | −$46.9m | −$13.2m |
| Operating margin | -8058.8% | -4713.8% |
| Net margin | -7533.6% | -4574.4% |
| Return on equity | -125.9% | — |
| Free cash flow | −$29.8m | −$10.0m |
| Cash | $11.9m | $3.2m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 115 | — |
| Market value | $1.7m | $40.3m |
| Price vs our value range | — | — |
| Moat score | 24 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 4 buys, 7 sales |